In the largest genomics study of clear cell endometrial cancer (CCEC) tumors to date, National Human Genome Research Institute (NHGRI) researchers and their collaborators have identified mutations in the TAF1 gene. They've ...
May 9, 2017
0
42
Scientists have uncovered how tumor cells in aggressive uterine cancer can switch disguises and spread so quickly to other parts of the body. In a study published in Neoplasia, researchers at the Washington University School ...
Mar 30, 2017
0
0
PI3K (phosphoinositide 3-kinase) is a cell-signaling molecule that has now been implicated in a large number of women's cancers including breast, ovarian and endometrial cancers.
Jan 28, 2016
1
5
Endometriosis - tissue usually found inside the uterus that grows outside - thrives because of altered cellular signaling that is mediated by estrogen, said researchers from Baylor College of Medicine in a report that appears ...
Nov 5, 2015
0
21
Researchers at Uppsala University have, together with researchers from Turku and Bergen, discovered a new biomarker which makes it possible to identify women with uterine cancer who have a high risk of recurrence. The findings ...
Apr 14, 2015
0
4
The Australian first Women's Health, Creating Change trial will focus on women's reproductive cancers, such as ovarian, breast and endometrial cancer.
Nov 19, 2014
0
0
A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine.
Aug 19, 2014
0
0
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, ...
Jun 11, 2013
0
0
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a molecule that inhibits the action of estrogen. This female hormone plays a key role in the growth, maintenance and repair of reproductive ...
May 9, 2012
0
0
